Popular Keywords
Adrenal Disorders
Breast Cancer and Ovarian Cancer
Endocrine Diseases
Gynecology and Obstetrics
Hormone
Leukoencephalopathy
Correspondence to Author: Muhammad Ahsan Akhtar,
Consultant Gynaecologist, Reproductive Medicine, RCOG accredited sub specialist in Reproductive Medicine, Fakih IVF Fertility Centre Abu Dhabi, United Arab Emirates.
Abstract:
Background Anti-Müllerian hormone (AMH) is widely
recognised as the gold standard for assessing ovarian
reserve. It is also utilised to predict ovarian response during
controlled ovarian stimulation in assisted reproductive
technology (ART) and is key indicator of oocyte yield, embryo
quality, embryo euploidy, and live birth rates.
Methods This multicentre retrospective study analysed
the prevalence of AMH levels in women aged 18–50 years
who attended Fakih IVF Fertility Centres (Abu Dhabi, Al Ain,
and Dubai) in the UAE for their initial fertility consultation
between 2017 and 2023. AMH levels were classified as
normal (≥1.3 ng/mL) or low (1.3 ng/mL).
Results: A total of 8,533 women underwent AMH testing,
with 63.62% having normal AMH levels and 36.38% showing
low AMH levels. No significant differences in AMH levels
were observed across demographic groups. From 2017 to
2021, normal AMH levels remained stable at around 63-65%,
but in 2022-2023, they declined to 58-59%, indicating a 5-7%
increase in the number of patients with low AMH. This rise was
particularly notable, with a 4.3-8.3% increase in women under
30 and a 7.7-9.5% increase in those aged 31-40.
Conclusion This study reveals a decline in AMH levels across
all age groups during 2022-2023 compared to the previous
five years, with a more significant decrease noted in women
under 40. Given AMH’s role as a key predictor of successful
ART outcomes, early intervention for women under 40 years
particularly those under 35, may be crucial for improving ART
success. Further research with a larger sample size is necessary
to confirm these findings.
Citation:
Muhammad Ahsan Akhtar .Trends in Anti-Mullerian Hormone levels among Women attending Fertility Clinic in the UAE. Journal of Clinical Obstetrics and Gynecology Research 2024.
Journal Info
- Journal Name: Journal of Clinical Obstetrics and Gynecology Research
- Impact Factor: 2.203*
- ISSN: 2766-2756
- DOI: 10.52338/Jocogr
- Short Name: Jocogr
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
INDEXING
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility